MiR-192-5p-Modified Tumor-Associated Macrophages-Derived Exosome Suppressed Endometrial Cancer Progression Through

Yilin Wang1, Hongsheng Ma2, Yajie Li3

  • 1Department of Obstetrics and Gynecology, Inner Mongolia People's Hospital, 20 Zhaowuda Road, Saihan District, Hohhot City, Inner Mongolia, China.

Insights

Tumor-associated macrophages promote endometrial cancer (EC) via exosomes. Upregulating miR-192-5p in these exosomes inhibits cancer progression and tumor growth, offering a new EC treatment target.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Tumor-associated macrophages (TAMs) significantly influence endometrial cancer (EC) development.
  • TAMs communicate with cancer cells through exosome transfer, carrying microRNAs (miRNAs).

Purpose of the Study:

  • To investigate the role of TAM-derived exosomes and miR-192-5p in EC progression.
  • To explore the therapeutic potential of modulating miR-192-5p in EC treatment.

Main Methods:

  • Analysis of TAM-exosome interaction with EC cells.
  • Quantification of miR-192-5p levels in TAM-derived exosomes.
  • In vitro and in vivo experiments assessing the effects of miR-192-5p overexpression.
  • Investigation of the IRAK1/NF-κB signaling pathway.

Main Results:

  • TAMs promote EC cell epithelial-mesenchymal transition (EMT) and inhibit apoptosis.
  • TAM-derived exosomes mediate these effects; miR-192-5p is downregulated within them.
  • Overexpression of miR-192-5p in TAM exosomes promotes EC cell apoptosis, impedes EMT, and inhibits tumor growth.
  • miR-192-5p targets IRAK1, inhibiting the IRAK1/NF-κB pathway.

Conclusions:

  • Overexpression of miR-192-5p in TAM-derived exosomes suppresses EC progression by inhibiting the IRAK1/NF-κB pathway.
  • This finding presents a novel therapeutic strategy for endometrial cancer.